Hospitals
San Francisco city has 12 general acute care hospitals. They also have 31 hospitals and primary care medical facilities and three speciality hospitals.
As the historic birthplace of biotechnology, San Francisco remains the premier global hub for biopharmaceutical innovation and venture capital investment. The ecosystem is anchored by the Mission Bay life sciences cluster, a high-density district where world-class academic research institutions like UCSF drive pioneering discoveries in genomic medicine and regenerative therapies. Global pharmaceutical giants, including Genentech and Roche, leverage this proximity to collaborate with a dense network of clinical-stage biotechs and agile startups.
Beyond traditional drug development, the region leads the world in healthcare innovation, specifically the integration of artificial intelligence (AI) into drug discovery and digital health platforms.
The medical device sector thrives here by blending Silicon Valley’s hardware expertise with cutting-edge robotic surgery and wearable diagnostic technologies.
Strategic proximity to Stanford University and the Gladstone Institutes ensures a continuous pipeline of elite talent and intellectual property that fuels the next generation of precision medicine.
With a robust infrastructure of CLIA-certified laboratories and specialized incubators, San Francisco provides an unparalleled environment for translational research and global commercialization.
San Francisco city has 12 general acute care hospitals. They also have 31 hospitals and primary care medical facilities and three speciality hospitals.
The San Francisco metro area is home to 34 undergraduate colleges, 12 universities and technical schools, employing more than 56,000 people and generating over $10 billion in annual revenue. Notable research anchors include the University of California, San Francisco (R1, AAU), Stanford University (R1, AAU) and UC Berkeley (R1, AAU), along with the University of San Francisco, California College of the Arts and Samuel Merritt University.
Bay Area institutions received $2.1 billion in NIH funding in 2025, with UCSF and Stanford gathering the bulk of the capital.
Bay Area life sciences companies attracted $11.3 billion in venture capital in 2024.
The Bay Area is home to 3,638 life sciences establishments spanning digital health, biopharma, AI-based therapeutics and more.
Major biopharma companies with a presence in or near San Francisco include Roche/Genentech, Gilead, AbbVie, Amgen and Bristol Myers Squibb.
San Francisco is home to 43 medical equipment companies, including players like Capstan Medical, Clarify Health Solutions and Siren Care, forming a growing cluster of medtech and digital health innovators.
There are over 2,000 ongoing clinical studies in San Francisco, covering a broad range of therapeutic areas and phases.
San Francisco, California, United States, USA
The Bay Area employed over 122,000 life sciences workers in 2025, including researchers, manufacturing specialists and support roles.
The San Francisco Bay Area had 41,332,583 ft² of lab and manufacturing space in Q1 2025, with another 1,517,666 ft² that was under development.
Claim Profile to Update Website
Claim Profile to Update Contact Information
Claim Your Profile to Add Related Links
Claim Your Profile to add downloadable documentation
https://pharmaville.com/wp-content/uploads/2025/09/Pharmaville-San-Francisco-references.pdf